SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.

作者: CP-Y Lau , RT-P Poon , S-T Cheung , W-C Yu , S-T Fan

DOI: 10.1002/PATH.2068

关键词:

摘要: Both Secreted Protein Acidic and Rich in Cysteine (SPARC) Hevin are multifunctional matricellular glycoproteins. Recent experimental studies suggested that SPARC together diminish angiogenesis, but their significance hepatocellular carcinoma (HCC) remains unclear. This study aimed to correlate expression with angiogenesis clinicopathological features HCC. protein mRNA HCC specimens were assessed by immunostaining, immunoblotting, quantitative reverse transcriptase-polymerase chain reaction. Tumour microvessel density (MVD) was CD34 immunostaining. The role of further an vivo nude mice xenograft model. levels significantly higher tumours than non-tumourous livers. A significant correlation between tumour found. Moreover, localized the sinusoidal area correlated cells. Truncated forms proteins detected clinical samples. MVD. On other hand, overexpression full-length xenografts athymic delayed growth, this delay related a decrease angiogenesis. Expression within cells presence encapsulation absence hepatitis B surface antigen Overexpression also growth. In conclusion, has shown upregulated compared liver, they inter-related at both levels. progression.

参考文章(34)
Alexandre Chlenski, Olga V. Volpert, Amy Evangelista, Robert Farrer, James Bray, Susan L. Cohn, Susan L. Cohn, Susan E. Crawford, Qiwei Yang, Helen R. Salwen, George H. DeVries, Shuqing Liu, SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Research. ,vol. 62, pp. 7357- 7363 ,(2002)
A Claeskens, N Ongenae, J M Neefs, P Cheyns, P Kaijen, M Cools, E Kutoh, Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. British Journal of Cancer. ,vol. 82, pp. 1123- 1130 ,(2000) , 10.1054/BJOC.1999.1051
Kenji Oritani, Paul W. Kincade, Lymphopoiesis and Matrix Glycoprotein SC1/ECM2 Leukemia & Lymphoma. ,vol. 32, pp. 1- 7 ,(1998) , 10.3109/10428199809059241
Thomas H Barker, Paul Framson, Pauli A Puolakkainen, May Reed, Sarah E Funk, E Helene Sage, None, Matricellular Homologs in the Foreign Body Response: Hevin Suppresses Inflammation, but Hevin and SPARC Together Diminish Angiogenesis American Journal of Pathology. ,vol. 166, pp. 923- 933 ,(2005) , 10.1016/S0002-9440(10)62312-7
Peter Schraml, Igor Bendik, Christian U. Ludwig, Characterization of MAST9/Hevin, a SPARC-like Protein, That is Down-Regulated in Non-Small Cell Lung Cancer Cancer Research. ,vol. 58, pp. 626- 629 ,(1998)
Erhard Hohenester, Patrik Maurer, Rupert Timpl, CRYSTAL STRUCTURE OF A PAIR OF FOLLISTATIN-LIKE AND EF-HAND CALCIUM-BINDING DOMAINS IN BM-40 The EMBO Journal. ,vol. 16, pp. 3778- 3786 ,(1997) , 10.1093/EMBOJ/16.13.3778
Millicent M. Sullivan, E.Helene Sage, Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family. The International Journal of Biochemistry & Cell Biology. ,vol. 36, pp. 991- 996 ,(2004) , 10.1016/J.BIOCEL.2004.01.017
Joanne E. Murphy-Ullrich, The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? Journal of Clinical Investigation. ,vol. 107, pp. 785- 790 ,(2001) , 10.1172/JCI12609